Shanton Pharma
Shanton Pharma Receives EMA and FDA Pediatric Study Waivers for SAP-001 in Hyperuricemia
Pediatric clinical studies of SAP-001 in hyperuricemia and gout are not needed Significant clinical trial burden and costs avoided due to waiver…
Company newsroom
1 releases
Pediatric clinical studies of SAP-001 in hyperuricemia and gout are not needed Significant clinical trial burden and costs avoided due to waiver…